Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growth. - Tocheny CE; Buchwald JE; Dahlke CD; Fakih HH; Morgan JS; Summers A; Wisniewski CA; Jackson SO; Lee JS; Card MA; Echeverria D; Peterson C; et al. (BioRxiv : the preprint server for biology, 2025)